OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director received an award of 12K ARWR shares | OQRO

Home
Insider trades
Arrowhead Pharmaceuticals
Director received an award of 12K ARWR shares

Insider trades

Insider trade

Director received an award of 12K ARWR shares

Traded Jun 15, 2026 · Filed Jun 18, 2026

ARWArrowhead PharmaceuticalsARWR

12K
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 15, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 18, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0002141314-26-000004
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Jun 18, 2026, 1:44 AM UTC

Added to OQRO

Oct 6, 2026, 4:40 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

Issuer CIK

879407

Ticker

ARWR

Reporting person

Matthew Gregory Cohen

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jun 15, 2026

Transaction code

Shares / units

11,882

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

11,882

Ownership form

Direct

Amendment

Footnotes from the filing

Represents shares underlying restricted stock units with a grant date 06/15/2026, which will vest over three years.

Around the same time

Director sold ~$228K of Arrowhead Pharmaceuticals

Scheduled in advance5mo ago

CFO sold ~$225K of Arrowhead Pharmaceuticals

Scheduled in advance6mo ago

CFO sold ~$82K of Arrowhead Pharmaceuticals

Scheduled in advance6mo ago